The Evolution of “Robustness-in-Use”: Moving Beyond HbA1c in Diabetes Tech
For years, the success of diabetes technology has been measured by a few key metrics: HbA1c levels and Time in Range (TIR). While these numbers are vital for clinical health, they often fail to capture the lived reality of athletes pushing their bodies to the absolute limit.
In the world of ultra-endurance sports—think 100km trail runs, long-distance cycling, and triathlons—the goal shifts. It is no longer just about perfect optimization; it is about robustness-in-use. This is the ability to maintain “good-enough” stability despite unpredictable terrain, extreme heat, and the physical toll of prolonged exertion.
The future of diabetes management is moving toward a model where technology doesn’t just chase a number, but supports the user’s ability to adapt and improvise when the environment becomes chaotic.
The Next Frontier: Context-Aware Algorithms
Current Automated Insulin Delivery (AID) and Hybrid Closed-Loop (HCL) systems are marvels of engineering, but they often struggle with the physiological volatility of extreme sports. Athletes frequently report a “mismatch” between how an algorithm behaves and how their body reacts during a long aerobic effort.
The trend is shifting toward context-aware algorithms. Instead of a generic “exercise mode,” future systems may proactively detect prolonged aerobic activity or allow for more intuitive, user-controlled targets that are simple to set and revert.
Until these systems evolve, athletes rely on “continuous anticipation.” This means projecting glucose trajectories hours in advance—adjusting basal rates 60 to 120 minutes before a race starts to prevent the dreaded hypoglycemic crash during the first few climbs.
Closing the Gap Between Algorithmic Promise and Reality
There is a persistent gap between what a device is designed to do in a controlled setting and how it performs in the wild. For instance, some users of advanced systems like Control-IQ have noted that the automation can actually increase mental load because the user must constantly monitor and override the device’s decisions to fit the reality of the sport.
Future iterations will likely focus on transparency—giving the user clearer signals about why the device is making a specific decision, thereby reducing the emotional labor of hyper-vigilance.
Experienced ultra-athletes don’t trust a single point of failure. To build “user-generated robustness,” always carry a redundancy kit: spare pods, extra catheters, medical-grade adhesives, and a backup CGM or traditional capillary glucose meter.
Hardware Durability: The War Against “Device Fragility”
No matter how smart the software is, it is useless if the hardware fails. In ultra-endurance contexts, “device fragility” is a major hurdle. Sweat, friction from running gear, and extreme temperature swings can lead to adhesive failure or catheters being ripped off mid-race.
We are seeing a move toward materials science integration in diabetes tech. The focus is shifting toward:
- Advanced Adhesives: Development of patches that can withstand hours of heavy perspiration and mechanical stress.
- Optimized Placement: Moving beyond standard sites to find areas less prone to friction during specific athletic movements.
- Ruggedized Housings: Protecting pumps and sensors from the accidental impacts common in trail running or cycling.
The Synergy of Data and “Gut Feel”
One of the most surprising trends is the resurgence of embodied knowledge. While CGM data is invaluable, the most successful athletes use it as a supplement to—not a replacement for—their own bodily cues.
When a sensor drifts or a pump fails, athletes revert to “going by feel,” relying on years of experience to interpret sensations of fatigue, heat, and digestive signals. The future of diabetes care isn’t about replacing human intuition with AI, but about creating a hybrid expertise where the user can seamlessly switch between data-driven projection and experiential sensing.
Visibility as a Catalyst for Community and Identity
Diabetes technology is becoming more than a medical necessity; it is becoming a social interface. For many, wearing a pump or sensor in plain sight during a race is a symbolic act of ownership and resistance against the narrative of fragility.
This visibility serves two powerful purposes:
- Advocacy: Showing younger people with T1D and their parents that “the disease doesn’t stop us” and that We find no limits to what is possible.
- Connection: Devices often act as conversation starters, breaking the solitude of a chronic condition and creating a “family” feel among endurance athletes.
Frequently Asked Questions
Q: Can AID/HCL systems completely automate glucose management during a marathon?
A: Not yet. While they provide significant gains in stability, they still require substantial user input, such as carbohydrate announcements and anticipatory basal adjustments.
Q: What is “robustness-in-use”?
A: It is the ability of a user and their technology to maintain functional stability despite environmental perturbations, focusing on “good-enough” control rather than laboratory-level precision.
Q: Why do some athletes find that automation increases their mental load?
A: Because they must spend cognitive energy monitoring the algorithm’s decisions and overriding them when the software doesn’t align with the physiological demands of the sport.
As we move forward, the goal for clinicians and designers is clear: move beyond the clinic and into the wild. By prioritizing material durability, context-aware software, and the validation of user expertise, we can ensure that technology truly empowers athletes to redefine their limits.
Are you an athlete living with T1D? How do you handle device failures during long efforts?
Share your strategies in the comments below or subscribe to our newsletter for more insights on the intersection of health tech and performance.
